Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Ixion Biotechnology

Dedicated to discovering and developing breakthrough cell-based therapies for metabolic disorders including primary hyperoxaluria, kidney stones, and other oxalate-related conditions, and insulin-dependent diabetes.


Contact Details:
13709 Progress Boulevard Box 13
Alachua
FL
32615
United States of America
Tel:904 418 1428
Fax:904 418 1583
Email:
WWW:

www.ixion-biotech.com/




Loading...

Recent Publications by Ixion Biotechnology:

Immobilization of an oxalate-degrading enzyme on silicone elastomer.
Urinary biomaterials are compromised by device-related urinary tract...
14th June, 2003
Ixion Biotechnology, Inc, 13709 Progress Boulevard, P O Box 13, Alachua, J Biomed Mater Res. 2002;63(6):822-9.
DOI Direct Link
Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells.
Ductal structures of the adult pancreas contain stem cells that...
25th March, 2000
Ixion Biotechnology, 13709 Progress Blvd., Box 13, Alachua, Florida 32615, Nat Med. 2000 Mar;6(3):278-82.
DOI Direct Link

BioNews Results for Ixion Biotechnology:

Cougar Biotechnology, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 1:01AM Matching: biotechnology
Global Biotechnology - New Report Published
OfficialSpin:  Nov 15 2009 7:32PM Matching: biotechnology
Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
Financials.com:  Nov 15 2009 10:55PM Matching: biotechnology
XTEN Data From Amunix and Versartis Featured in Nature Biotechnology as a Novel Platform for Increasing Serum
Genetic Engineering News:  Nov 15 2009 8:47PM Matching: biotechnology
XTEN Data From Amunix and Versartis Featured in Nature Biotechnology as a Novel Platform for Increasing Serum
Sys-Con Canada:  Nov 15 2009 8:39PM Matching: biotechnology
Promote your company here: BioNewsCast - Press Release Distribution

View more Ixion Biotechnology news.

Ixion Biotechnology Patents:

US Patent No.Title
7202080 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
6703017 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
6699469 Materials and methods for treating or preventing oxalate-related disease
6355242 Materials and methods for treating or preventing oxalate-related disease
6200562 Method for reducing absorption of dietary oxalate using enzymes and microbes

View more Ixion Biotechnology patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 588 times since April 2007, the link to the organisation's website has been followed 116 times

Recent Search Terms used to find this page: ixion biotechnology 2008 | ixion biotechnology | ixion biotechnology | ixion biotechnology oxalate 2008..2009 | Ixion | .

Search for more companies in Alachua

Search for more companies in FL



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ixion Biotechnology

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.